Physician profile
Arthur M Smith
NPI 1043211444
$3,006.42
in general payments reported to CMS, 2019-2025
23 companies · $251 in 2025
The $251 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $837 · 2020: $325 · 2021: $234 · 2022: $255 · 2023: $462 · 2024: $643 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,355.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $958.85 | 2019-2024 | Ultreon, Coroflow, Mitraclip |
| Actelion Pharmaceuticals US, INC. | $410.06 | 2019-2021 | |
| Boston Scientific Corporation | $378.06 | 2019-2024 | |
| Abiomed | $250.43 | 2019-2024 | Impella |
| Biotronik INC. | $153.39 | 2019 | |
| Shockwave Medical, INC | $142.62 | 2021-2025 | |
| Inari Medical, INC. | $116.34 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Acist Medical Systems, INC. | $98.89 | 2022-2024 | |
| Impulse Dynamics (USA) INC. | $86.96 | 2023 | Optimizer |
| Edwards Lifesciences Corporation | $64.91 | 2021 | |
| Pfizer INC. | $39.63 | 2025 | |
| Endovascular Engineering INC. | $39.62 | 2024-2025 | Helo Thrombectomy System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.19 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $33.42 | 2019-2022 | |
| Novo Nordisk INC | $33.40 | 2025 | Ozempic |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $24.95 | 2021 | |
| Medtronic Vascular, INC. | $24.46 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.15 | 2025 | |
| Atricure, INC. | $23.88 | 2023 | |
| Janssen Pharmaceuticals, INC | $22.34 | 2019 | |
| Chiesi USA, INC. | $14.85 | 2021 | |
| Siemens Medical Solutions USA, INC. | $13.57 | 2023 | Naeotom Alpha |
| Novartis Pharmaceuticals Corporation | $13.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.